Need extra support quickly? We are working with clients around the world right now to help them tackle new challenges from COVID-19.  

How can we help you? Learn More >

Dr. Colin Wheeler

Vice President, European Regulatory Affairs

Dr. Colin Wheeler is the Vice President of European Regulatory Affairs at ProPharma Group. Dr. Wheeler has worked in the global pharmaceutical industry for over 20 years in Regulatory and Clinical Development roles. Colin was previously CEO and founder of Southwood Research Ltd, a UK and Netherlands based consultancy company within the fields of Regulatory and Development Sciences, which he founded in 2016. Southwood Research was acquired by ProPharma Group in 2019.

Colin is a UK certified physician and has worked in various global roles in across companies such as Merck, Takeda and Celgene, including time spent working both in the EU and US. He has worked extensively in the areas of Hematology and Oncology, and has a particular interest in Paediatric and Orphan Diseases. Colin has broad experience of presenting to global regulatory agencies including the EMA, FDA and PMDA. Colin qualified in Medicine (MBChB) from Glasgow University, and has a post graduate diploma in Pharmaceutical Medicine (DipPharmMed) from the University of Cardiff. Colin is a fellow of the Faculty of Pharmaceutical Medicine (FFPM).

Company Blog

April 1, 2020
COVID-19 Pandemic in the EU: Fraudulent Medicines, Test Kit Shortage,…
The COVID-19 pandemic is creating many new challenges for our industry around the world.… Read More
March 31, 2020
Ten Tips for Conducting Successful Virtual FDA Meetings in the…
Ten tips for Sponsors now facing virtual FDA meetings rather than face-to-face interactions, and how to… Read More
March 25, 2020
Health Authorities’ Information on the COVID-19 Pandemic Throughout Europe, Part…
How is COVID-19 affecting clinical trials across Europe? Hanneke Dominicus provides more information on… Read More
More Articles

UPCOMING Events

All Events
Contact Us